Publicacións nas que colabora con María Fuencisla Gilsanz Muñoz (2)

2021

  1. Mir-7, mir-10a and mir-143 expression may predict response to bevacizumab plus chemotherapy in patients with metastatic colorectal cancer

    Pharmacogenomics and Personalized Medicine, Vol. 14, pp. 1263-1273

2020

  1. Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports

    World journal of gastroenterology, Vol. 26, Núm. 16, pp. 1979-1986